5N9B | pdb_00005n9b

Crystal Structure of unliganded human IL-17RA

External Resource: Annotation

Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	Fibronectin type III	8092065	3002063	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	Fibronectin type III	8092066	3002063	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	IL17R_fnIII_D1	e5n9bA1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: Immunoglobulin-related	T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like	F: IL17R_fnIII_D1	ECOD (1.6)
A	IL17R_fnIII_D2	e5n9bA2	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: Immunoglobulin-related	T: Immunoglobulin/Fibronectin type III/E set domains/PapD-like	F: IL17R_fnIII_D2	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	2.60.40.2160	Mainly Beta	Sandwich	Immunoglobulin-like	Interleukin-17 receptor A/B, fibronectin-III-like domain 1	CATH (utative)
A	2.60.40.2150	Mainly Beta	Sandwich	Immunoglobulin-like	Interleukin-17 receptor A/B, fibronectin-III-like domain 2	CATH (utative)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A	PF16578	Interleukin 17 receptor D (IL17R_fnIII_D2)	Interleukin 17 receptor D	IL17R_fnIII_D2 is the second extracellular fibronectin III-like domain on interleukin17-receptor-D molecules. The exact ligands of IL17R-D are not known [1,2,3].	Domain
A	PF16556	Interleukin-17 receptor, fibronectin-III-like domain 1 (IL17R_fnIII_D1)	Interleukin-17 receptor, fibronectin-III-like domain 1	IL17R_fnIII_D1 is the first of two fibronectin 3-like domains on interleukin-17 receptor proteins A and B. The tow fnIII domains are linked and together bind two molecules of IL-17 at one of its receptor-binding interfaces. This allows the other int ...	IL17R_fnIII_D1 is the first of two fibronectin 3-like domains on interleukin-17 receptor proteins A and B. The tow fnIII domains are linked and together bind two molecules of IL-17 at one of its receptor-binding interfaces. This allows the other interface to bind to another receptor, thus allowing the IL-17 family of homodimeric cytokines to coordinate two different receptors [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A	Interleukin-17 receptor A	protein binding binding signaling receptor binding molecular transducer activity interleukin-17 receptor activity transmembrane signaling receptor activity signaling receptor activity cytokine receptor activity immune receptor activity	multicellular organismal process regulation of cellular process positive regulation of biological process positive regulation of macromolecule biosynthetic process positive regulation of metabolic process regulation of interleukin-5 production positive regulation of biosynthetic process regulation of cytokine production cytokine production regulation of multicellular organismal process positive regulation of macromolecule metabolic process interleukin-5 production positive regulation of cellular process regulation of biosynthetic process multicellular organismal process regulation of cellular process positive regulation of biological process positive regulation of macromolecule biosynthetic process positive regulation of metabolic process regulation of interleukin-5 production positive regulation of biosynthetic process regulation of cytokine production cytokine production regulation of multicellular organismal process positive regulation of macromolecule metabolic process interleukin-5 production positive regulation of cellular process regulation of biosynthetic process regulation of biological process biological regulation regulation of macromolecule metabolic process gene expression macromolecule biosynthetic process regulation of gene expression biosynthetic process positive regulation of gene expression positive regulation of multicellular organismal process regulation of macromolecule biosynthetic process metabolic process cellular process macromolecule metabolic process positive regulation of cytokine production regulation of metabolic process positive regulation of interleukin-5 production cellular response to stimulus cell surface receptor signaling pathway response to stimulus signaling response to cytokine interleukin-17A-mediated signaling pathway cytokine-mediated signaling pathway cell communication response to peptide response to chemical cellular response to cytokine stimulus signal transduction regulation of defense response regulation of response to external stimulus defense response response to external stimulus regulation of inflammatory response positive regulation of response to stimulus positive regulation of response to external stimulus positive regulation of inflammatory response regulation of response to stimulus regulation of response to stress response to stress positive regulation of defense response inflammatory response adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains immune response immune system process adaptive immune response T-helper 17 type immune response interleukin-13 production positive regulation of interleukin-13 production regulation of interleukin-13 production interleukin-6 production positive regulation of interleukin-6 production regulation of interleukin-6 production cell chemotaxis chemotaxis granulocyte migration leukocyte migration cellular response to chemical stimulus taxis granulocyte chemotaxis myeloid leukocyte migration cell migration cell motility leukocyte chemotaxis locomotion biological process involved in interspecies interaction between organisms response to other organism defense response to symbiont response to biotic stimulus defense response to other organism innate immune response response to external biotic stimulus catabolic process primary metabolic process protein catabolic process protein metabolic process macromolecule catabolic process chemokine (C-X-C motif) ligand 1 production regulation of chemokine production chemokine production positive regulation of chemokine production regulation of chemokine (C-X-C motif) ligand 1 production positive regulation of chemokine (C-X-C motif) ligand 1 production fibroblast activation cell activation cellular response to interleukin-17 response to interleukin-17 interleukin-17-mediated signaling pathway defense response to fungus response to fungus positive regulation of interleukin-23 production interleukin-23 production regulation of interleukin-23 production response to virus regulation of cytokine production involved in inflammatory response production of molecular mediator involved in inflammatory response cytokine production involved in inflammatory response positive regulation of cytokine production involved in inflammatory response	cell periphery cellular anatomical structure plasma membrane membrane extracellular region

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A	IPR043046	Interleukin-17 receptor A/B, FnIII-like domain 2 superfamily	Homologous Superfamily
A	IPR013568	SEFIR domain	Domain
A	IPR038683	Interleukin-17 receptor A/B, FnIII-like domain 1 superfamily	Homologous Superfamily
A	IPR032356	IL17RA/B, N-terminal domain	Domain
A	IPR039465	Interleukin-17 receptor-like	Family

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A	Pharos: Q96F46	chronic mucocutaneous candidiasis immunodeficiency 51 brain ischemia psoriasis astrocytic tumor Cerebral Ischemia glioblastoma lung carcinoma medulloblastoma osteosarcoma pituitary cancer tuberculosis hepatocellular carcinoma malignant glioma nail disease chronic mucocutaneous candidiasis immunodeficiency 51 brain ischemia psoriasis astrocytic tumor Cerebral Ischemia glioblastoma lung carcinoma medulloblastoma osteosarcoma pituitary cancer tuberculosis hepatocellular carcinoma malignant glioma nail disease ovarian cancer candidiasis exocrine pancreatic carcinoma malignant pancreatic neoplasm pilocytic astrocytoma

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.